Penry Price joins Mawdsleys
Penry Price joins Mawdsleys 21st February 2015

Mawdsleys is delighted to welcome Penry Price to the company to head up the generic purchasing division (February 2015).

 

Penry, who joins Mawdsleys from Alliance Healthcare, has been appointed to work alongside Gary Winkle, the new Purchasing Director.

 

Penry has many plans for the generic portfolio at Mawdsleys which all involve continuing to develop the generic proposition.

 

Penry says “It’s great to now be heading up the generic portfolio at Mawdsleys.  I am looking forward to putting my plans into place and ensuring Mawdsleys remains the competitive player in the market that it is.”

 

Other latest news
https://www.mawdsleys.co.uk/news/were-proud-to-support-intouniversity-salford/ thumbnail image We’re proud to support IntoUniversity Salford

It’s been almost 18 months since we began our relationship with IntoUniversity Salford Central at the Beacon Centre in Salford - the partnership between IntoUniversity, the University of Salford and the University of Manchester. Mawdsleys is one of the cornerstone funders of the centre, which supports over 1000 young people…

Read more
https://www.mawdsleys.co.uk/news/mawdsleys-and-oncoscience-launch-a-named-patient-program-for-cimaher-nimotuzumab-in-the-uk-and-ireland/ thumbnail image Mawdsleys and Oncoscience launch a Named Patient Program for CIMAher®

Mawdsleys and Oncoscience GMbH have launched a Named Patient Supply Program to allow Oncologists in the United Kingdom (UK) and Ireland to obtain access to CIMAher® (Nimotuzumab) on an unlicensed basis for the treatment of various types of cancer.   Nimotuzumab has been approved for marketing in 25 different countries worldwide for a variety of…

Read more